Dr. Scott Rocklage is the Co-manager of 5 AM Ventures. He joined this company in the year 2003 and became a co-manager one year later. Rocklage has a profound experience of more than three decades in the health care management system. Dr. Scott Rocklage strategic leadership was after the approval of some drug application in the United States. These drug applications incorporate Omniscan, Cubicin as well as Teslascan. He has served in various health care organizations which includes Salutar and Catalytica, Nycomed Salutar, Cubist Pharmaceuticals, Relypsa, and Novira.
Dr. Scott Rocklage was the Chairman and the Chief Executive Officer of Cubist Pharmaceuticals. When he was in Nycomed Salutar, he used to serve as the President as well as the Chief Executive Officer of the firm. He carried massive research and established positions in Salutar and …show more content…
He is a graduate of two most prominent universities in America. He attained Bachelors of Science degree in Chemistry from the University of California (UC) which is based in Berkeley. After this, he proceeded to Massachusetts Institute of Technology (MIT) for Ph.D. in Chemistry. Rocklage considers himself lucky since he got an opportunity to run his research in Richard R. Schrock’s laboratory. Richard R. Schrock was the winner of the Nobel Prize in the year 2005 for his achievements in Chemistry.
Dr. Scott Rocklage is awarded for inventing over 30 American patents. He has published over hundred Peer-reviewed research papers. He sits in 5 AM ventures offices which are located in Boston. He is the Board of Associates at Whitehead Institute. This is a nonprofit educational institute as well as a research institute for biomedical research. The special accomplishments of Dr. Scott Rocklage rank him as one of the most influential personalities in the healthcare management department in the